Published in Nephrol Dial Transplant on May 17, 2007
Calcium metabolism in the early posttransplantation period. Clin J Am Soc Nephrol (2009) 0.97
Mineral and bone disorders in kidney transplant recipients: reversible, irreversible, and de novo abnormalities. Clin Exp Nephrol (2015) 0.85
Association between long-term efficacy of cinacalcet and parathyroid gland volume in haemodialysis patients with secondary hyperparathyroidism. NDT Plus (2008) 0.83
Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention. NDT Plus (2008) 0.80
Measuring total blood calcium displays a low sensitivity for the diagnosis of hypercalcemia in incident renal transplant recipients. Clin J Am Soc Nephrol (2010) 0.77
Rapid decrease of intact parathyroid hormone could be a predictor of better response to cinacalcet in hemodialysis patients. Yonsei Med J (2013) 0.76
Long-term clinical practice experience with cinacalcet for treatment of hypercalcemic hyperparathyroidism after kidney transplantation. Biomed Res Int (2015) 0.75
The renal arterial resistance index and renal allograft survival. N Engl J Med (2003) 4.36
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. Lancet (2011) 2.82
Vascular endothelial growth factor-A and aldosterone: relevance to normal pregnancy and preeclampsia. Hypertension (2013) 2.70
Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients. Kidney Int (2009) 2.39
Outcome of home haemodialysis patients: a case-cohort study. Nephrol Dial Transplant (2005) 2.21
Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int (2008) 2.00
Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. J Clin Invest (2004) 1.87
Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol (2010) 1.82
Functional evaluation of transplanted kidneys with diffusion-weighted and BOLD MR imaging: initial experience. Radiology (2006) 1.52
Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients. Am J Hypertens (2008) 1.51
Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant (2005) 1.50
High aldosterone-to-renin variants of CYP11B2 and pregnancy outcome. Nephrol Dial Transplant (2009) 1.49
The relative myocardial blood volume differentiates between hypertensive heart disease and athlete's heart in humans. Eur Heart J (2006) 1.45
The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant (2005) 1.44
Reduced 11beta-hydroxysteroid dehydrogenase activity in experimental nephrotic syndrome. Nephrol Dial Transplant (2002) 1.44
Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension. J Hypertens (2012) 1.43
Treatment of acute renal failure in the intensive care unit: lower costs by intermittent dialysis than continuous venovenous hemodiafiltration. Artif Organs (2009) 1.43
Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant (2009) 1.34
Hypoxia up-regulates expression of Eph receptors and ephrins in mouse skin. FASEB J (2005) 1.18
First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am J Obstet Gynecol (2008) 1.12
Evaluation of renal allograft function early after transplantation with diffusion-weighted MR imaging. Eur Radiol (2009) 1.07
Effect of tenofovir on renal glomerular and tubular function. AIDS (2007) 1.05
A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients. J Clin Endocrinol Metab (2003) 1.03
Serum cytokine profile in patients with active lupus nephritis. Cytokine (2012) 1.01
Reference values and factors associated with renal resistive index in a family-based population study. Hypertension (2013) 1.00
Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells. Am J Physiol Endocrinol Metab (2008) 1.00
Non-invasive monitoring of renal oxygenation using BOLD-MRI: a reproducibility study. NMR Biomed (2006) 0.97
Prematurity is related to high placental cortisol in preeclampsia. Pediatr Res (2009) 0.95
Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess. J Am Soc Nephrol (2007) 0.93
Statin therapy and the expression of genes that regulate calcium homeostasis and membrane repair in skeletal muscle. Am J Pathol (2010) 0.93
Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers. Clin J Am Soc Nephrol (2011) 0.93
Regulation of placental growth by aldosterone and cortisol. Endocrinology (2010) 0.92
Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Transplantation (2002) 0.92
Heritability, determinants and reference values of renal length: a family-based population study. Eur Radiol (2013) 0.92
The Reuse of Immunoadsorption Columns in ABO-Incompatible Kidney Transplantation Is Efficient: The Swiss Experience. Transplantation (2015) 0.91
Gain-of-function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation. Hum Mol Genet (2008) 0.91
The 11-ketosteroid 11-ketodexamethasone is a glucocorticoid receptor agonist. Mol Cell Endocrinol (2004) 0.91
Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor. J Biol Chem (2002) 0.91
Identification of polymorphisms in the human 11beta-hydroxysteroid dehydrogenase type 2 gene promoter: functional characterization and relevance for salt sensitivity. FASEB J (2007) 0.91
Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation. Epigenetics (2011) 0.90
Salt sensitivity of children with low birth weight. Hypertension (2008) 0.90
PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers. Nephrol Dial Transplant (2008) 0.89
Tumor necrosis factor alpha and phorbol 12-myristate-13-acetate down-regulate human 11beta-hydroxysteroid dehydrogenase type 2 through p50/p50 NF-kappaB homodimers and Egr-1. FASEB J (2005) 0.88
Role of the alpha-adducin genotype on renal disease progression. Kidney Int (2002) 0.88
DHEA induces 11 -HSD2 by acting on CCAAT/enhancer-binding proteins. J Am Soc Nephrol (2007) 0.87
Glutamate-115 renders specificity of human 11beta-hydroxysteroid dehydrogenase type 2 for the cofactor NAD+. Mol Cell Endocrinol (2003) 0.87
In vivo footprinting of the human 11beta-hydroxysteroid dehydrogenase type 2 promoter: evidence for cell-specific regulation by Sp1 and Sp3. J Biol Chem (2002) 0.87
Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species. J Mol Endocrinol (2005) 0.87
Intrarenal arterial aneurysms with haematuria in a patient with tuberous sclerosis complex. Nephrol Dial Transplant (2005) 0.87
Arterial stiffness assessed by digital volume pulse correlates with comorbidity in patients with ESRD. Am J Kidney Dis (2006) 0.86
Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis. J Am Soc Nephrol (2003) 0.86
Glycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria. J Am Soc Nephrol (2002) 0.86
CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. J Clin Endocrinol Metab (2004) 0.85
Use of Pavo cristatus feather extract for the better management of snakebites: neutralization of inflammatory reactions. J Ethnopharmacol (2005) 0.85
Nephrotoxicity of rapamycin: an emerging problem in clinical medicine. Nephrol Dial Transplant (2005) 0.84
Increased cortisol metabolites and reduced activity of 11beta-hydroxysteroid dehydrogenase in patients on hemodialysis. Kidney Int (2002) 0.84
Hexose-6-phosphate dehydrogenase modulates 11beta-hydroxysteroid dehydrogenase type 1-dependent metabolism of 7-keto- and 7beta-hydroxy-neurosteroids. PLoS One (2007) 0.84
Urinary proteomics before and after extracorporeal circulation in patients with and without acute kidney injury. J Thorac Cardiovasc Surg (2010) 0.84
Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysis. Thromb Haemost (2007) 0.84
A naturally occurring human Nedd4-2 variant displays impaired ENaC regulation in Xenopus laevis oocytes. Am J Physiol Renal Physiol (2004) 0.83
Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade. J Hypertens (2002) 0.83
'Pergularain e I'--a plant cysteine protease with thrombin-like activity from Pergularia extensa latex. Thromb Res (2009) 0.83
Hypoxia causes down-regulation of 11 beta-hydroxysteroid dehydrogenase type 2 by induction of Egr-1. FASEB J (2003) 0.83
Living renal allograft transplantation: diffusion-weighted MR imaging in longitudinal follow-up of the donated and the remaining kidney. Radiology (2013) 0.83
Gene delivery by a steroid-peptide nucleic acid conjugate. FASEB J (2002) 0.82
Metabolomics reveals the metabolic map of procainamide in humans and mice. Biochem Pharmacol (2012) 0.82
Smaller left kidney in low birth weight children. Kidney Int (2012) 0.82
Normotensive blood pressure in pregnancy: the role of salt and aldosterone. Hypertension (2013) 0.81
Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine era. Transpl Int (2006) 0.81
Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients. Clin Pharmacokinet (2002) 0.81
Salt-sensitivity of blood pressure and decreased 11beta-hydroxysteroid dehydrogenase type 2 activity after renal transplantation. Transplantation (2002) 0.81
Effect of transcutaneous electrical muscle stimulation and passive cycling movements on blood pressure and removal of urea and phosphate during hemodialysis. Am J Kidney Dis (2008) 0.81
High salt intake down-regulates colonic mineralocorticoid receptors, epithelial sodium channels and 11β-hydroxysteroid dehydrogenase type 2. PLoS One (2012) 0.81
Angiotensin II regulates 11beta-hydroxysteroid dehydrogenase type 2 via AT2 receptors. Kidney Int (2003) 0.81
Nocturnal dipping behaviour in normotensive white children and young adults in response to changes in salt intake. J Hypertens (2010) 0.81
Evidence for a role of sterol 27-hydroxylase in glucocorticoid metabolism in vivo. J Endocrinol (2013) 0.81
Relationship between renal resistance index and renal function in liver transplant recipients after cessation of calcineurin inhibitor. Clin Transplant (2009) 0.80
Cholesterol acceptor capacity is preserved by different mechanisms in preterm and term fetuses. Biochim Biophys Acta (2014) 0.80
Ambulatory arterial stiffness index is increased in hypertensive childhood disease. Pediatr Res (2008) 0.79
Pulse contour analysis: a valid assessment of central arterial stiffness in children? Pediatr Nephrol (2007) 0.79
Modulation of renal calcium handling by 11 beta-hydroxysteroid dehydrogenase type 2. J Am Soc Nephrol (2002) 0.79